Microbix Biosystms (MBX) Stock Statistics & Valuation Metrics

Microbix Biosystms has a market cap or net worth of C$47.87M. The enterprise value is C$44.17M.

Microbix Biosystms has 140,797,030 shares outstanding. The number of shares has decreased by -2.65% in one year.

Microbix Biosystms’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 10.72%.

The current PE Ratio of Microbix Biosystms is 13.01. Microbix Biosystms’s PEG ratio is -0.49.

In the last 12 months, Microbix Biosystms had revenue of 25.39M and earned 3.52M in profits. Earnings per share was 0.03.

In the last 12 months, operating cash flow was 3.80M and capital expenditures -2.07M, giving a free cash flow of 1.73M billion.

Microbix Biosystms pays an annual dividend of ―, resulting in a dividend yield of ―

Microbix Biosystms upcoming earnings date is Aug 13, 2025, TBA Not Confirmed.

Microbix Biosystms as a current ratio of 7.15, with Debt / Equity ratio of 22.29%

In the past 12 months, Microbix Biosystms has paid 150.56K in taxes.

Microbix Biosystms EV to EBITDA ratio is 6.32, with an EV/FCF ratio of 16.07.

Microbix Biosystms has C$13.05M in cash and marketable securities with C$6.44M in debt, giving a net cash position of -C$6.61M billion.

Gross margin is 56.11%, with operating margin of 15.38%, and net profit margin of 13.86%.

The average price target for Microbix Biosystms is C$0.80, which is 11.43% higher than the current price. The consensus rating is Moderate Buy